Financhill
Buy
54

FUJHY Quote, Financials, Valuation and Earnings

Last price:
$9.17
Seasonality move :
2.24%
Day range:
$8.97 - $9.18
52-week range:
$7.32 - $11.27
Dividend yield:
3.74%
P/E ratio:
6.03x
P/S ratio:
0.43x
P/B ratio:
0.74x
Volume:
41K
Avg. volume:
104.2K
1-year change:
-16.62%
Market cap:
$13.4B
Revenue:
$30.8B
EPS (TTM):
$1.52
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $26.7B $24.4B $28B $32.6B $30.8B
Revenue Growth (YoY) -13.23% -8.43% 14.34% 16.6% -5.61%
 
Cost of Revenues $22.1B $20B $22.5B $25.7B $24.3B
Gross Profit $4.6B $4.5B $5.5B $6.9B $6.4B
Gross Profit Margin 17.41% 18.36% 19.51% 21.1% 20.92%
 
R&D Expenses $982.5M $922.7M $847.2M $786.6M $935.2M
Selling, General & Admin $2.6B $2.7B $2.5B $2.8B $2.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.7B $3.7B $3.5B $3.6B $3.8B
Operating Income $967.7M $817.4M $2B $3.3B $2.7B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $1.1B $952.9M $2.1B $3.7B $2.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $345.6M $324M $587.1M $1B $724.5M
Net Income to Company $1.1B $952.9M $2.1B $3.7B $2.9B
 
Minority Interest in Earnings -$7.6M -$5.2M $10M $3.6M -$590.9K
Net Income to Common Excl Extra Items $721.7M $623.6M $1.5B $2.7B $2.2B
 
Basic EPS (Cont. Ops) $0.47 $0.41 $0.97 $1.76 $1.50
Diluted EPS (Cont. Ops) $0.47 $0.41 $0.97 $1.76 $1.50
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $3.1B $3B $4B $5.3B $4.8B
EBIT $1.2B $981.4M $2.3B $3.8B $3.3B
 
Revenue (Reported) $26.7B $24.4B $28B $32.6B $30.8B
Operating Income (Reported) $967.7M $817.4M $2B $3.3B $2.7B
Operating Income (Adjusted) $1.2B $981.4M $2.3B $3.8B $3.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.2B $5.9B $7.5B $8.7B $8.3B
Revenue Growth (YoY) 1.46% -28.57% 28.01% 15.88% 5.6%
 
Cost of Revenues $6.6B $4.8B $5.9B $6.6B $6.5B
Gross Profit $1.6B $1.1B $1.6B $2.1B $1.9B
Gross Profit Margin 19.19% 18.6% 20.91% 24.05% 22.26%
 
R&D Expenses $210.2M $199M $181.6M $151M $201.8M
Selling, General & Admin $702.7M $654M $636.9M $666.1M $681.7M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $926.7M $888.8M $834.7M $830M $888.8M
Operating Income $646.9M $200.5M $733.3M $1.3B $964.5M
 
Net Interest Expenses -- -- $60.2M -- --
EBT. Incl. Unusual Items $666.3M $264.6M $672.2M $1.3B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $182.3M $108M $133.9M $283.4M $332.1M
Net Income to Company $671.8M $247M $654.7M $1.3B --
 
Minority Interest in Earnings -$411.7K $2.5M $4.8M -$142.2K -$209.8K
Net Income to Common Excl Extra Items $483.5M $159M $543.1M $1B $1B
 
Basic EPS (Cont. Ops) $0.32 $0.10 $0.35 $0.67 $0.69
Diluted EPS (Cont. Ops) $0.32 $0.10 $0.35 $0.67 $0.69
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $1.2B $775.5M $1.3B $1.9B $1.4B
EBIT $707.4M $272.2M $853.7M $1.5B $999.1M
 
Revenue (Reported) $8.2B $5.9B $7.5B $8.7B $8.3B
Operating Income (Reported) $646.9M $200.5M $733.3M $1.3B $964.5M
Operating Income (Adjusted) $707.4M $272.2M $853.7M $1.5B $999.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $26.8B $24.4B $27.9B $32.5B $31.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $22.1B $19.9B $22.5B $25.7B $24.6B
Gross Profit $4.7B $4.5B $5.4B $6.9B $6.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $981.1M $923.5M $847.9M $786.5M $944.2M
Selling, General & Admin $2.6B $2.7B $2.5B $2.7B $2.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.7B $3.7B $3.5B $3.6B $3.8B
Operating Income $979M $821.6M $2B $3.2B $2.7B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $1.1B $957.4M $2B $3.7B $3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $348.6M $323.8M $582.4M $1B $733.8M
Net Income to Company $1.1B $952.9M $2.1B $3.7B --
 
Minority Interest in Earnings -$7.6M -$5.3M $9.8M $3.8M -$595.8K
Net Income to Common Excl Extra Items $729.6M $628.3M $1.5B $2.7B $2.2B
 
Basic EPS (Cont. Ops) $0.48 $0.41 $0.96 $1.76 $1.52
Diluted EPS (Cont. Ops) $0.48 $0.41 $0.96 $1.76 $1.52
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.1B $3B $4B $5.6B $4.8B
EBIT $1.2B $1B $2.2B $4.1B $3.3B
 
Revenue (Reported) $26.8B $24.4B $27.9B $32.5B $31.1B
Operating Income (Reported) $979M $821.6M $2B $3.2B $2.7B
Operating Income (Adjusted) $1.2B $1B $2.2B $4.1B $3.3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $18.1B $20.6B $24.4B $15.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $14.6B $16.5B $19.2B $12.1B --
Gross Profit $3.4B $4B $5.2B $3.3B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $700.7M $585M $567.7M $357.3M --
Selling, General & Admin $2B $1.8B $2B $1.3B --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.7B $2.5B $2.6B $1.7B --
Operating Income $695.1M $1.6B $2.6B $1.5B --
 
Net Interest Expenses -- $60.2M -- -- --
EBT. Incl. Unusual Items $822.1M $1.6B $2.9B $2B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $253.3M $448.3M $825.5M $486.1M --
Net Income to Company $802.7M $1.5B $2.8B -- --
 
Minority Interest in Earnings -$1.9M $6.1M $3.9M -$293.2K --
Net Income to Common Excl Extra Items $566.9M $1.1B $2.1B $1.6B --
 
Basic EPS (Cont. Ops) $0.37 $0.73 $1.37 $1.05 --
Diluted EPS (Cont. Ops) $0.37 $0.73 $1.37 $1.05 --
Weighted Average Basic Share $4.6B $4.6B $4.5B $3B --
Weighted Average Diluted Share $4.6B $4.6B $4.5B $3B --
 
EBITDA $2.4B $3.2B $4.4B $2.6B --
EBIT $902.6M $1.9B $3.3B $1.8B --
 
Revenue (Reported) $18.1B $20.6B $24.4B $15.3B --
Operating Income (Reported) $695.1M $1.6B $2.6B $1.5B --
Operating Income (Adjusted) $902.6M $1.9B $3.3B $1.8B --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $8.2B $7.2B $7.4B $6.9B $6.3B
Short Term Investments $2.1B $2B $2.9B $5.8B $6.8B
Accounts Receivable, Net $3.1B $2.8B $2.7B $2.5B $2.8B
Inventory $3.8B $4B $4.5B $3.9B $4.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $601.7M $632M $745.8M $784.9M $891.3M
Total Current Assets $18B $16.7B $18.2B $19.9B $21.3B
 
Property Plant And Equipment $7.6B $6.9B $6.5B $6.4B $7.1B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.2B $1.3B $1.4B $1.5B $1.6B
Total Assets $30.9B $29B $29.6B $31.8B $34B
 
Accounts Payable $2.4B $2.2B $2.8B $2.5B $2.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.9B $2.5B $2.6B $2.9B $3.3B
Total Current Liabilities $7.9B $7B $7.6B $8.1B $8.4B
 
Long-Term Debt $2.8B $2.3B $1.9B $2.2B $2.4B
Capital Leases -- -- -- -- --
Total Liabilities $14.7B $13.5B $13.8B $14.9B $15.9B
 
Common Stock $1.4B $1.3B $1.2B $1B $1B
Other Common Equity Adj -- -- -- -- --
Common Equity $16.1B $15.5B $15.8B $16.9B $18.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $78.4M $83.8M $67.3M $14.5M $8M
Total Equity $16.2B $15.6B $15.8B $16.9B $18.1B
 
Total Liabilities and Equity $30.9B $29B $29.6B $31.8B $34B
Cash and Short Terms $10.3B $9.2B $10.3B $12.7B $13.1B
Total Debt $3B $2.7B $2.3B $2.6B $2.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $8.2B $7.2B $7.4B $6.9B $6.3B
Short Term Investments $2.1B $2B $2.9B $5.8B $6.8B
Accounts Receivable, Net $3.1B $2.8B $2.7B $2.5B $2.8B
Inventory $3.8B $4B $4.5B $3.9B $4.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $601.7M $632M $745.8M $784.9M $891.3M
Total Current Assets $18B $16.7B $18.2B $19.9B $21.3B
 
Property Plant And Equipment $7.6B $6.9B $6.5B $6.4B $7.1B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.2B $1.3B $1.4B $1.5B $1.6B
Total Assets $30.9B $29B $29.6B $31.8B $34B
 
Accounts Payable $2.4B $2.2B $2.8B $2.5B $2.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.9B $2.5B $2.6B $2.9B $3.3B
Total Current Liabilities $7.9B $7B $7.6B $8.1B $8.4B
 
Long-Term Debt $2.8B $2.3B $1.9B $2.2B $2.4B
Capital Leases -- -- -- -- --
Total Liabilities $14.7B $13.5B $13.8B $14.9B $15.9B
 
Common Stock $1.4B $1.3B $1.2B $1B $1B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $78.4M $83.8M $67.3M $14.5M $8M
Total Equity $16.2B $15.6B $15.8B $16.9B $18.1B
 
Total Liabilities and Equity $30.9B $29B $29.6B $31.8B $34B
Cash and Short Terms $10.3B $9.2B $10.3B $12.7B $13.1B
Total Debt $3B $2.7B $2.3B $2.6B $2.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.1B $952.9M $2.1B $3.7B $2.9B
Depreciation & Amoritzation $1.9B $2B $1.8B $1.5B $1.5B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $230.7M $68.5M -$111M -$50.7M -$203.8M
Change in Inventories $373.2M -$377.2M -$681.7M $359M -$607.2M
Cash From Operations $2.7B $1.7B $3.7B $5.3B $3.2B
 
Capital Expenditures $1.8B $1.7B $1.4B $2.1B $1.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.6B -$1.6B -$2.5B -$4.9B -$2.7B
 
Dividends Paid (Ex Special Dividend) -$405.1M -$382.4M -$374.7M -$451.8M -$516.3M
Special Dividend Paid
Long-Term Debt Issued $995.2M $231.6M $222.2M $987.5M $453M
Long-Term Debt Repaid -$70M -$222.6M -$378.8M -$383.9M -$453M
Repurchase of Common Stock -- -- -$29.6K -$277.2M -$393.9M
Other Financing Activities -$1.9M -$472.1K -$7.4K -$37.7M -$4.9M
Cash From Financing $131.7M -$877.4M -$905.8M -$460.6M -$1.2B
 
Beginning Cash (CF) $8.1B $8.1B $6.5B $6.8B $6.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $294M -$735.5M $330.6M -$17.3M -$651.7M
Ending Cash (CF) $8.6B $7.9B $7.3B $7.3B $6.2B
 
Levered Free Cash Flow $913.6M $83.8M $2.3B $3.2B $1.5B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $501.5M $63M $150.2M $535.6M $871.7M
Depreciation & Amoritzation $457.3M $490.9M $516.5M $524.4M $422.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$145.4M $15.7M -$41.7M -$46M -$86.8M
Change in Inventories -$377.7M $387.5M $5.6K -$147.4M $377.9M
Cash From Operations $745.1M $1B $986.8M $1.4B $2.2B
 
Capital Expenditures $477.1M $528.5M $451.3M $451.6M $617.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$254.1M -$463.6M -$484.4M -$1.1B -$2B
 
Dividends Paid (Ex Special Dividend) -$1.6M $5.4M -$5.6M -$16.5M -$11M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $621.4M -$14.9M $2.9M $200.9M $499.9M
Long-Term Debt Repaid -$50M -$2M -$91.8M -$308.2M -$171.9M
Repurchase of Common Stock -- -- -- -$29.6K -$6.3M
Other Financing Activities -$10.2K -$19.4K -$32.3K $21K -$855.2K
Cash From Financing $508.2M -$106.4M -$221.4M -$237.4M $214.5M
 
Beginning Cash (CF) $7B $7.9B $7.2B $6.8B $6.6B
Foreign Exchange Rate Adjustment -$49.7M $353M $319M $49.3M $221.9M
Additions / Reductions $999.2M $430.8M $280.9M $120.1M $325.3M
Ending Cash (CF) $7.9B $8.6B $7.9B $7.3B $7.3B
 
Levered Free Cash Flow $268M $472.2M $535.4M $969M $1.5B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $1.5B $865.7M $1.7B $3.4B --
Depreciation & Amoritzation $1.9B $2B $1.8B $1.6B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $69.6M $125.9M -$106.7M -$10M --
Change in Inventories -$392M $10.3M -$534.3M -$166.3M --
Cash From Operations $2.5B $1.8B $3.3B $4.6B --
 
Capital Expenditures $1.8B $1.7B $1.4B $1.9B $1.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.4B -$1.6B -$1.9B -$3.9B --
 
Dividends Paid (Ex Special Dividend) -$412.1M -$371.4M -$363.8M -$457.4M -$243.8M
Special Dividend Paid
Long-Term Debt Issued $1.6B $213.8M -- -- --
Long-Term Debt Repaid -$118M -$132.8M -$162.4M -$520.2M --
Repurchase of Common Stock -- -- -- -$271M --
Other Financing Activities -$1.9M -$459.3K -- -$36.8M --
Cash From Financing $746.3M -$762.4M -$889.7M -$912.5M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $862.4M -$585.6M $491.4M -$222.6M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $709.4M $20.6M $1.9B $2.7B --
Period Ending 2021-06-02 2022-06-02 2023-06-02 2024-06-02
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is IONQ The Next NVIDIA?
Is IONQ The Next NVIDIA?

Quantum computing startup IonQ (NYSE:IONQ) has seen its stock skyrocket…

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for Jun 2

Regeneron Pharmaceuticals [REGN] is up 0.05% over the past day.

Buy
55
RGC alert for Jun 2

Regencell Bioscience Holdings [RGC] is down 19.04% over the past day.

Sell
42
AMBA alert for Jun 2

Ambarella [AMBA] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock